CUE - Cue Biopharma, Inc.
Previous close
1.09
0.010 0.917%
Share volume: 1,709
Last Updated: Fri 27 Dec 2024 08:25:23 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.25%
PREVIOUS CLOSE
CHG
CHG%
$1.08
0.01
0.93%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-04 | 2022-11-14 | 2023-03-21 | 2023-05-09 | 2023-08-08 | 2023-11-03 | 2024-03-28 | 2024-05-09 | |
| Total revenue | 26.000 K | 68.000 K | 151.227 K | 187.000 K | 1.382 M | 2.100 M | 1.821 M | 1.717 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 26.000 K | 68.000 K | 151.227 K | 187.000 K | 1.382 M | 2.100 M | 1.821 M | 1.717 M | |
| 161.54% | 122.39% | 23.66% | 639.04% | 51.95% | -13.29% | -5.71% | |||
| Operating expenses | 13.374 M | 11.099 M | 15.036 M | 13.567 M | 14.899 M | 13.519 M | 15.497 M | 14.385 M | |
| Selling general and admin | 3.782 M | 3.528 M | 3.703 M | 4.176 M | 4.249 M | 3.645 M | 4.610 M | 4.186 M | |
| Research and development | 9.592 M | 7.571 M | 11.333 M | 9.391 M | 10.650 M | 9.874 M | 10.887 M | 10.199 M | |
| Total expenses | 13.374 M | 11.099 M | 15.036 M | 13.567 M | 14.899 M | 13.519 M | 15.497 M | 14.385 M | |
| -17.01% | 35.47% | -9.77% | 9.82% | -9.26% | 14.63% | -7.18% | |||
| Operating income | -13.348 M | -11.031 M | -14.884 M | -13.380 M | -13.517 M | -11.419 M | -13.676 M | -12.668 M | |
| Ebit | -13.348 M | -11.031 M | -14.884 M | -13.380 M | -13.517 M | -11.419 M | -13.676 M | -12.668 M | |
| Pretax income | -13.208 M | -10.955 M | -14.592 M | -13.109 M | -13.185 M | -11.005 M | -13.434 M | -12.347 M | |
| -17.06% | 33.20% | -10.17% | 0.58% | -16.53% | 22.07% | -8.09% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -13.208 M | -10.955 M | -14.592 M | -13.109 M | -13.185 M | -11.005 M | -13.434 M | -12.347 M | |
| 17.06% | -33.20% | 10.17% | -0.58% | 16.53% | -22.07% | 8.09% | |||
| Net income | -13.208 M | -10.955 M | -14.592 M | -13.109 M | -13.185 M | -11.005 M | -13.434 M | -12.347 M | |
| 17.06% | -33.20% | 10.17% | -0.58% | 16.53% | -22.07% | 8.09% |